Copyright © 2021 Pharmascimed. All Rights Reserved.
Pfizer
Pfizer/Lilly announce more positive results for pain drug
- February 21, 2019
- 0
Pfizer and Eli Lilly have revealed more positive results for their non-opioid pain drug tanezumab - with significant improvements in chronic lower pack pain (CBLP). The results come from a phase III...
Read more
Pfizer’s biosimilar Zirabev gains EU approval
- February 21, 2019
- 0
Pfizer has won European Commission approval for its Avastin biosimilar Zirabev (bevacizumab). The approval comes on the back of data from the phase III REFLECTIONS B739-03 clinical comparative study which...
Read more